Abstract
Introduction: Bleeding is the most common major complication from colonoscopic polypectomy. We performed a meta-analysis to evaluate whether submucosal epinephrine injections prevent postpolypectomy bleeding. Methods: The dataset was defined by searching PubMed for randomized controlled and retrospective studies published before December 2021 that compared the use of epinephrine (alone or with another preventative measure) to no prophylaxis for bleeding. Groups were defined as either epinephrine injection only (group A), mechanical prophylaxis via detachable snare and/or clip only (group B), combined therapy group (group C), and a control group. Group differences were analyzed by using a random-effects models. Effect sizes were calculated as Cohen’s d for continuous data or a log of the odds ratio (OR) for percentage (binary) data. Results: In all, we identified ten studies: six used in a prior meta-analysis and four additional studies (Table). Overall, 2,125 patients with 2,287 total polyps were included in nine randomized controlled trials and one retrospective chart review. Overall bleeding was lower in group A than in controls on the basis of five studies (OR, -1.038; confidence interval [CI] -1.560 to -0.515; p≤0.001). One study indicated that overall bleeding was lower in group B than in the controls (OR, -1.524; CI, -2.799 to -0.249; p=0.019) (Figure A). Early bleeding was lower in group A than in the controls on the basis of five studies (OR, -1.626; CI, -2.535 to -0.718; p≤0.001) and lower in group B on the basis of one study (OR, -2.719; CI, -4.175 to -1.263; p≤0.001) (Figure B). There were no significant group differences associated with late onset bleeding. Group A was significantly older than group C (Figure C) and had larger polyps than group B (Figure D). Homogeneity tests indicated homogeneity among the effect sizes suggesting examination of moderating variables was not necessary and there were no differences among the groups in terms of patient sex, polyp histology, polyp morphology, or stalk size. Conclusion: The results indicate that epinephrine prophylaxis reduces overall and early postpolypectomy bleeding but does not affect late bleeding.Figure 1.: Comparison of (A) overall and (B) early postpolypectomy bleeding in the epinephrine and control group. (C) Group A was significantly older than Group C. (D) Group A identified larger polyp size than Group B. Table 1. - Study Characteristics (NA, not available; mm, millimeters) Study Population Group Comparisons Number of patients Age (year) Number of polyps Polyp size (mean) (mm) Rohde NA A: Epinephrine B: No prophylaxis NA A: 70 (53–88), B: 65 (33–78) 40 A: 15 (7–28), B: 15 (11–35) Lee SH. Multicenter A: Epinephrine B: No prophylaxis 486 A: 51.6 ± 11.4, B: 56.8 ± 11.3 561 A: 14.5 ± 5.7, B: 15.0 ± 6.8 Hsieh Yh. Single center A: Epinephrine B: No prophylaxis 129 A: 62.9 (59.8–62.1), B: 64.9 (62.1–67.8) 151 A: 8.0 (8–13), B: 8.0 (8–11) Dobrowolski S. Single center A: Epinephrine B: No prophylaxis 69 A: 63.7 ± 9.7, B: 66.8 ± 11.5 100 A: 16.3 ± 5.4, B: 16.1 ± 5.9 Paspatis GA. Multicenter A: Combined therapy (detachable snare with epinephrine) B: Epinephrine 159 A: 61.7 ± 13.8, B: 64.5 ± 11 159 A: 27.1 ± 8.9, B: 26.3 ± 8.1 Kouklakis G. Single center A: Mechanical therapy (Endoloop with postpolypectomy clipping) B: Epinephrine 64 A: 57.9 ± 9.7, B: 58.8 ± 11.2 64 A: 25.6 ± 12.0, B: 27.0 ± 11.0 Di Giorgio P. Single center A: Mechanical therapy (detachable snare) B: Epinephrine C: No prophylaxis 488 A: 64 ± 9.2, B: 63 ± 8.9, C: 62 ± 9.0 488 A: 22.2 ± 5.9, B: 24.7 ± 5.3, C: 21.6 ± 4.8 Yamaguchi Single center A: Epinephrine B: No prophylaxis 204 A: 73.7 ± 8.7, B: 73.7 ± 8.3 204 A: 10.0 ± 5.8, B: 10.0 ± 5.0 Bahin Multicenter A: Combined therapy (epinephrine and succinylated gelatin injection with electrocoagulation) B: Epinephrine and succinylated gelatin injection 347 A: 66.0, B: 70.0 347 A: 39.5, B: 39.8 Park Multicenter A: Combined therapy (clipping with epinephrine) B: Mechanical therapy (clipping) 148 A: 59 ± 11, B: 60 ± 10 173 A: 17.5 ± 6.7, B: 17.2 ± 6.6
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.